About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Cytokine Levels in Conversion Disorder | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNCT00971360

Cytokine Levels in Conversion Disorder

The aim of this study is whether the proinflammatory cytokine levels in patients with conversion disorder is increased or not changed in the acute phase and subacute - chronic periode, compared with c...

Lead sponsor: Trakya University•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Sponsors

Lead Sponsor

Trakya University

Age

18 - 65 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Clinical diagnosis of Alzheimer's Disease

Exclusion Criteria

•Autoimmune disease
•Neurological disease
•Any organic disorder that could possibly affect proinflammatory cytokines
•Pregnancy
•Any drug usage within 2 weeks
•Any active or passive immunization within 6 months
•Any other DSM-IV axis I psychiatric disorder
•Mental retardation
•Developmental disorder of childhood

Related studies

Observational Study on "Functional Overlay" in Patients With Movement Disorders

NCT05943652 · Conversion Disorder, Parkinson Disease, and more

Metabolic Anomolies Associated With the 6 Month Clinical Evolution of Patients Suffering From Motor Conversion Disorder

NCT02329626 · Conversion Disorder

Neuroimaging Biomarkers of Prognosis in Motor Functional Neurological Disorders

NCT03398070 · Conversion Disorder

Metacognitive Therapy and Neuro-physiotherapy as a Treatment for Functional Movement Disorders

NCT05323344 · Conversion Disorder

The Complexity of the Diagnostic Pathway of Children With a Functional Neurological Symptomatology Disorder

NCT05746637 · Conversion Disorder in Children

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: October 20, 2010Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment30

Start dateSep 2009

Last updatedOct 20, 2010

Condition

Conversion Disorder

Locations shown

Trakya University Faculty of Medicine; Department of Psychiatry

Edirne

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 20, 2010Data synced to Clareo: April 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions